Objectives Antenatal corticosteroids (ACS) decrease neonatal mortality and morbidity
among preterm neonates, yet there has been concern regarding their long-term safety. We …

Objective To evaluate the changes in the associations of antenatal corticosteroids (ACS)
with neonatal mortality and severe neurological injury over time (2003–17). Design National …

Aim To assess the effects of differential exposure to antenatal corticosteroid (ACS) on short-
and long-term outcomes of infants born before 24 weeks of gestation. Methods This is a …

Abstract Background The Multiple Courses of Antenatal Corticosteroids for Preterm Birth
Study (MACS) showed no benefit in the reduction of major neonatal mortality/morbidity or …

Objective To assess the impact of antenatal corticosteroids (ACS) on neonatal mortality,
cerebral lesions and 5‐year neurodevelopmental outcome of infants born at 24–27 and 28 …

Objective An increasing proportion of fetuses are exposed to antenatal corticosteroids
(ACS). Despite their immediate beneficial effects, the long-term safety of ACS has been an …

Importance Animal studies have found that antenatal corticosteroids affect many organs
across multiple stages of life. However, the long-term outcomes in human children are not …

Objective The antenatal late preterm steroids (ALPS) randomized trial noted decreased
short-term neonatal respiratory morbidity after antenatal exposure to betamethasone (BMZ) …

Importance The Antenatal Late Preterm Steroids (ALPS) trial changed clinical practice in the
United States by finding that antenatal betamethasone at 34 to 36 weeks decreased short …

Objective To update recommendations for administration of antenatal corticosteroids in the
late preterm period. Target Population Pregnant individuals at risk of preterm birth from 34 0 …